Form 4: AtriCure Director Maggie Yuen Reports Acquisition of Shares Through Restricted Stock Award

Director Maggie Yuen reports acquiring 5,401 shares of AtriCure, Inc. through a restricted stock award.

Summary

• On May 19, 2025, Maggie Yuen, a director of AtriCure, Inc., acquired 5,401 shares of common stock through a restricted stock award under the company's 2023 Stock Incentive Plan.
• The shares were acquired at a price of $0.
• Following the transaction, Yuen directly owns 14,371 shares of AtriCure common stock.
• The acquired shares will vest on the one-year anniversary of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares, even through a grant, suggests confidence in the company. However, it's a routine transaction.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.

Future Outlook

The shares acquired will vest one year from the grant date, indicating a commitment to the company's long-term performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

AtriCure, Director, Maggie Yuen, Stock Incentive Plan, Restricted Stock Award, Beneficial Ownership, Form 4, ATRC